Skip to content

Evaluation of Thyroglobulin in Fine-Needle Aspiration Fluid for Papillary Thyroid Carcinoma

Evaluation of Thyroglobulin in Fine-Needle Aspiration Fluid for Papillary Thyroid Carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900028547
Enrollment
Unknown
Registered
2019-12-27
Start date
2019-12-27
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid cancer

Interventions

Gold Standard:Pathology
aspiration-Tg

Sponsors

The First Affiliated Hospital, Medical School of Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. DTC patients aged 18-85 years with a clear clinical diagnosis; 2. Clinical data can be obtained for a complete evaluation of the efficacy; 3. Patients with a complete plan of clinical treatment can follow up the patient's progression-free survival (PFS); 4. Volunteer and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe liver and kidney damage 2. Pathology or long-term follow-up results may not be available; 3. Unable to obtain relevant control image data and clinical data; 4. Combined with other malignant tumors; 5. Beyond the age range or severely difficult to cooperate; 6. Failure to follow up on PFS; 7. Withdrawal of informed consent; 8. Missed follow-up; 9. Violates the research plan.

Design outcomes

Primary

MeasureTime frame
FNA-Tg;

Countries

China

Contacts

Public ContactRui Gao

the First Affiliated Hospital of Xi'an Jiaotong University School of Medicine

Jacky_mg@163.com+86 13772488039

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 21, 2026